ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,600Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 53

$2.12M Total Retail Price of All Prescriptions

Rank: 1 out of 53

637 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 637 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 8,273 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

57% of this provider’s prescriptions were for brand-name drugs, compared to an average of 46%.

Prescription Price

$156 was the average price of a prescription from this provider, compared to $123 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
SYNTHROID 783 488 1 2
ATORVASTATIN CALCIUM 553 330 2 12
LEVOTHYROXINE SODIUM 463 237 3 1
CRESTOR 407 280 4 20
LANTUS SOLOSTAR 352 197 5 5
BYSTOLIC 318 263 6 72
VITAMIN D2 294 227 7 83
GLIMEPIRIDE 293 182 8 10
ALLOPURINOL 264 160 9 51
PEN NEEDLE 247 130 10 4
ONGLYZA 246 162 11 41
FENOFIBRATE 240 138 12 29
METFORMIN HCL 223 128 13 3
TRILIPIX 223 157 13 43
SIMVASTATIN 216 87 15 6
LOVAZA 203 88 16 38
LANTUS 200 83 17 7
ACTOS 186 110 18 46
KOMBIGLYZE XR 181 101 19 104
SPIRONOLACTONE 171 83 20 59
TRICOR 169 77 21 45
FUROSEMIDE 160 97 22 16
AMLODIPINE BESYLATE 145 111 23 18
COREG CR 124 82 24 123
JANUVIA 122 53 25 14
OMEPRAZOLE 119 83 26 24
ZETIA 119 63 26 32
TRADJENTA 110 97 28 131
LISINOPRIL 110 57 28 8
NIASPAN 107 47 30 49
PRAVASTATIN SODIUM 107 88 30 17
BENICAR HCT 103 71 32 105
KLOR-CON M20 99 73 33 82
ANDROGEL 98 63 S3 34 76
METOPROLOL TARTRATE 96 57 35 26
EVISTA 87 87 36 115
PIOGLITAZONE HCL 86 47 R 37 90
LEVEMIR FLEXPEN 85 49 38 23
JANUMET 84 35 39 37
LIPITOR 83 35 40 92
CLOPIDOGREL 80 50 41 66
METOPROLOL SUCCINATE 79 60 42 34
ULORIC 77 64 43 143
HUMALOG MIX 75-25 75 38 44 36
CYMBALTA 73 19 45 68
INSULIN SYRINGE 72 16 46 9
WELCHOL 72 42 46 50
PLAVIX 71 48 48 65
EXFORGE 69 58 49 158
CARVEDILOL 68 59 50 61
SINGULAIR 65 53 51 111
AMITRIPTYLINE HCL 64 50 R 52 110
ZOLPIDEM TARTRATE 63 37 53 48
TRIBENZOR 62 49 54 165
ANTARA 61 53 55 167
HUMALOG 61 27 55 11
SERTRALINE HCL 59 33 57 63
PREDNISONE 57 17 58 79
TAMSULOSIN HCL 57 43 58 94
ACTOPLUS MET 56 23 60 128
BUMETANIDE 56 39 60 126
LOSARTAN-HYDROCHLOROTHIAZIDE 55 43 62 56
NATEGLINIDE 54 31 63 80
PANTOPRAZOLE SODIUM 54 31 63 84
VYTORIN 53 22 65 62
NEXIUM 53 49 65 35
AZOR 51 35 67 179
NOVOLOG FLEXPEN 51 0 67 13
GABAPENTIN 51 17 67 21
HUMALOG MIX 50-50 50 23 70 180
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.